Display options
Cite
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol. 2010;2doi: 10.3402/jom.v2i0.5344.
Vivekananda, M. R., Vandana, K. L., & Bhat, K. G. (2010). Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. Journal of oral microbiology, 2. https://doi.org/10.3402/jom.v2i0.5344
Vivekananda, M R, et al. "Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial." Journal of oral microbiology vol. 2 (2010). doi: https://doi.org/10.3402/jom.v2i0.5344
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. J Oral Microbiol. 2010 Nov 02;2. doi: 10.3402/jom.v2i0.5344. PMID: 21523225; PMCID: PMC3084569.
Copy Download .nbib Format: NLM
Share it on

J Oral Microbiol. 2010 Nov 02;2. doi: 10.3402/jom.v2i0.5344.

Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial.

Journal of oral microbiology

M R Vivekananda, K L Vandana, K G Bhat

Affiliations

  1. Department of Periodontics, Sri Hasanamba Dental College & Hospital, Hassan, Karnataka, India.

PMID: 21523225 PMCID: PMC3084569 DOI: 10.3402/jom.v2i0.5344

Abstract

OBJECTIVES: The aim of this study was to evaluate the effects of Lactobacilli reuteri (Prodentis) alone and in combination with scaling and root planing (SRP) in a double blind, randomized, placebo-controlled clinical trial of volunteers with chronic periodontitis.

METHODS: Thirty, otherwise systemically healthy, chronic periodontitis patients (19 males and 11 females, aged between 34 and 50 years) were included. The study period was 42 days. 'Split-mouth' design was used for the SRP, which was performed on day 0; two quadrants (either right or left) were treated with SRP whereas the remaining two quadrants were left untreated. The participants received a toothbrush, toothpaste, and brushing instructions. L. reuteri Prodentis lozenges (1×10(8) CFU DSM17938+1×10(8) CFU ATCC PTA 5289) or the corresponding placebo lozenges were taken twice daily from day 21 to day 42. Statistical analysis was done for comparisons of clinical parameters (Plaque Index (PI), Gingival Index (GI), Gingival Bleeding Index (GBI), probing pocket depth (PPD), clinical attachment level (CAL)) and microbiological levels of the pathogens Aggregibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), and Prevotella intermedia (Pi). All p-values less than 0.05 were considered significant. Assessments were made on day 0 before SRP treatment, on day 21 before administration of the lozenges, and on day 42.

RESULTS: At day 42, the PI, GI, and GBI were significantly reduced by all treatment modalities. When ranked, the amount of PI, GI and GBI reduction by the different treatments was SRP + Prodentis Prodentis SRP + placebo placebo; all differences were statistically significant. For PPD and CAL, the best result was obtained with the SRP+Prodentis treatment. PPD was reduced from 5.08±0.75 to 3.78±0.61 mm (p<0.001) and CAL from 3.93±0.93 to 2.85±0.74 mm (p<0.001). Prodentis, either alone or following SRP, reduced Aa, Pi, and Pg by 1 log(10) unit (p<0.01). The SRP+placebo combination did not significantly affect the levels of the pathogens.

CONCLUSION: The present randomized controlled trial confirms the plaque inhibition, anti-inflammatory, and antimicrobial effects of L. reuteri Prodentis. L. reuteri Prodentis probiotic can be recommended during non-surgical therapy and the maintenance phase of periodontal treatment. Considering the beneficial effects of probiotics, this therapy could serve as a useful adjunct or alternative to periodontal treatment when SRP might be contraindicated. Further studies are required in this direction.

Keywords: ATCC PTA 5289; DSM 17938; anti-inflammatory; antimicrobial; chronic generalized periodontitis; gingivitis; plaque; scaling and root planning

References

  1. Acta Odontol Scand. 2009;67(1):19-24 - PubMed
  2. J Clin Periodontol. 1998 Feb;25(2):134-44 - PubMed
  3. BMC Microbiol. 2009 Feb 11;9:35 - PubMed
  4. Acta Odontol Scand. 1963 Dec;21:533-51 - PubMed
  5. J Int Acad Periodontol. 2003 Oct;5(4):98-105 - PubMed
  6. J Clin Periodontol. 1991 Apr;18(4):219-22 - PubMed
  7. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005097 - PubMed
  8. Acta Odontol Scand. 1964 Feb;22:121-35 - PubMed
  9. J Clin Periodontol. 1984 Mar;11(3):193-207 - PubMed
  10. J Periodontal Res. 1980 Mar;15(2):123-36 - PubMed
  11. J Periodontol. 1982 May;53(5):296-301 - PubMed
  12. Int J Paediatr Dent. 2008 Jan;18(1):35-9 - PubMed
  13. J Periodontol. 1985 Apr;56(4):187-94 - PubMed
  14. BMC Microbiol. 2007 Nov 12;7:101 - PubMed
  15. J Dent Res. 2007 Nov;86(11):1078-82 - PubMed
  16. J Periodontal Res. 1980 Mar;15(2):144-51 - PubMed
  17. J Periodontol. 1990 Sep;61(9):579-84 - PubMed
  18. J Clin Periodontol. 1980 Jun;7(3):199-211 - PubMed
  19. J Clin Microbiol. 1982 Apr;15(4):606-9 - PubMed
  20. J Clin Periodontol. 2008 Oct;35(10):897-905 - PubMed
  21. Infect Immun. 2004 Sep;72(9):5308-14 - PubMed
  22. Ann Periodontol. 1999 Dec;4(1):1-6 - PubMed
  23. J Periodontol. 1994 Sep;65(9):820-6 - PubMed
  24. Microbiology (Reading). 2010 Jun;156(Pt 6):1589-1599 - PubMed
  25. Int Dent J. 1975 Dec;25(4):229-35 - PubMed
  26. Swed Dent J. 2006;30(2):55-60 - PubMed
  27. J Clin Periodontol. 1984 Jan;11(1):63-76 - PubMed
  28. Periodontol 2000. 2009;51:141-51 - PubMed

Publication Types